title: Congenital toxoplasmosis in a neonate with significant neurologic manifestations.
authors.affiliation: Department of Ophthalmology, Chung Shan Medical University Hospital, Taichung, Taiwan.
authors.forename: Ya-Cheng
authors.initials: YC
authors.lastname: Chuang
authors.forename: Jia-Yuh
authors.initials: JY
authors.lastname: Chen
authors.forename: Dar-Der
authors.initials: DD
authors.lastname: Ji
authors.forename: Pen-Hua
authors.initials: PH
authors.lastname: Su
mesh_terms: D000328:Adult; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001927:Brain Diseases / Q000473:pathology*; D005260:Female; D005317:Fetal Growth Retardation / Q000209:etiology*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging; D008297:Male; D011247:Pregnancy; D011739:Pyrimethamine / Q000008:administration & dosage / Q000627:therapeutic use; D060888:Real-Time Polymerase Chain Reaction; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use; D014122:Toxoplasma / Q000276:immunology / Q000302:isolation & purification; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D007075:Immunoglobulin M; D013411:Sulfadiazine; D011739:Pyrimethamine